Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
1 hedge funds and large institutions have $101 invested in Amedisys in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
75% less funds holding
Funds holding: 4 → 1 (-3)
100% less capital invested
Capital invested by funds: $57.6K → $101 (-$57.5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$47.7K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$7.27K |
| 3 |
MCI
MRP Capital Investments
Alpharetta,
Georgia
|
-$2.46K |
AMED Hedge Fund Activity: Q4 2025 in Review
1 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2025, worth a combined $101 — down 100% from $57.6K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AMED and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Osaic Holdings, exiting entirely with an estimated $47.7K sold.
- 1 institutional investor held Amedisys (AMED) as of Q4 2025, down from 4 in Q3 2025.
- Funds reported $101 of Amedisys stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new Amedisys positions in Q4 2025 and 3 closed out, a net change of -3 holders.
- The largest Amedisys seller in Q4 2025 was Osaic Holdings, an estimated $47.7K sold.
Based on aggregated 13F filings for Q4 2025.